Assessing Uniqueness of Inflammatory Bowel Disease Related Microbiome-derived Biomarkers

Clinical trial NCT05640583 · COMPLETED

Trial details

NCT number: NCT05640583
Sponsor: HyGIeaCare, Inc.
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Irritable Bowel Disease

Start date: 2022-03-16
Primary completion: 2023-03-06
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.